How a calculated oxidative stress can yield multiple therapeutic effects

References

• Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124–1136.
   PubMed Web of Science ®Google Scholar
• Bocci V. Paulesu L. Studies on the biological effects of ozone 1. Induction of interferon gamma on human leukocytes. Haematologica 1990;75:510–515.
   PubMed Web of Science ®Google Scholar
• Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Res Rev 2009;29:646–682.
   PubMed Web of Science ®Google Scholar
• Bocci V. Ozone. A new medical drug. 2nd edn. Dordrecht, The Netherlands: Springer; 2011.
   Google Scholar
• Bocci V. Is it true that ozone is always toxic? The end of the dogma. Toxicol Appl Pharmacol 2006;216:493–504.
   PubMed Web of Science ®Google Scholar
• Jerrett M, Burnett RT, Pope CA 3rd, Ito K, Thurston G, Krewski D, . Long-term ozone exposure and mortality. N Engl J Med 2009;360:1085–1095.
   PubMed Web of Science ®Google Scholar
• Moncada S. Nitric oxide gas: mediator, modulator and pathophysiologic entity. J Lab Clin Med 1992;120:187–191.
   PubMed Web of Science ®Google Scholar
• Verma A, Hirsch DJ, Glatt CE, Ronnett GV. Snyder SH. Carbon monoxide: a putative neural messenger. Science 1993;259:381–384.
   PubMed Web of Science ®Google Scholar
• Foresti R, Bani-Hani MG, Motterlini R. Use of carbon monoxide as a therapeutic agent: promises and challenges. Intensive Care Med 2008;34:649–658.
   PubMed Web of Science ®Google Scholar
• Nakao A, Sugimoto R, Billiar TR, McCurry KR. Therapeutic antioxidant medical gas. J Clin Biochem Nutr 2009;44:1–13.
   PubMed Web of Science ®Google Scholar
• Bannanberg GL, Vieira HL. Therapeutic applications of the gaseous mediators carbon monoxide and hydrogen sulphide Expert Opin Ther Pat 2009;19:663–682.
   Google Scholar
• George JF, Agarwal A. Hydrogen: another gas with the therapeutic potential. Kidney Int 2010;77:85–87.
   PubMedGoogle Scholar
• Barber E, Menendez S, Leon OS, Barber MO, Merino N, Calunga JL, Cruz E. Bocci V. Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischaemia. Mediators Inflamm 1999;8:37–41.
   PubMed Web of Science ®Google Scholar
• Hernandez F. Menendez S, Wong R. Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy. Free Radic Biol Med 1995;19:115–119.
   PubMed Web of Science ®Google Scholar
• Ajamieh HH, Berlanga J, Merino N, Sanchez GM, Carmona AM, Cepero SM. Role of protein synthesis in the protection conferred by ozone-oxidative-preconditioning in hepatic ischaemia/reperfusion. Transpl Int 2005;18:604–612.
   PubMed Web of Science ®Google Scholar
• Candelario-Jalil E, Mohammed-Al-Dalain S, Fernandez OS, Menendez S, Perez-Davison G, Merino N. Oxidative preconditioning affords protection against carbon tetrachloride-induced glycogen depletion and oxidative stress in rats. J Appl Toxicol 2001;21:297–301.
   PubMed Web of Science ®Google Scholar
• Rokitansky O, Rokitansky A, Steiner J, Trubel W, Viebahn R, Washuttl J. Die ozontherapie bei peripheren, arteriellen Durchblutlungs-storengen; Klinik, biochemische und blutgasanalytische Untersuchungen. Berlin: Wasser IOA, Ozon-Weltkongress; 1981. pp. 53–75.
   Google Scholar
• Mattassi R, D'Angelo F, Bisetti P, Colombo R, Vaghi M. Terapia con ozono per via parenterale nelle arteriopatie obliteranti periferiche: meccanismo biochimico e risultati clinici. Il Giornale di Chirurgia 1987;VIII:109–111.
   Google Scholar
• Giunta R, Coppola A, Luongo G, Sammartino A, Guastafierro S, Grassia A. Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease. Ann Hematol 2001; 80:745–748.
   PubMed Web of Science ®Google Scholar
• Di Paolo N, Bocci V, Cappelletti E, Petrini G, Gaggiotti E. Necrotizing fasciitis successfully treated with extracorporeal blood oxygenation and ozonation (EBOO). Int J Artif Organs 2002;25:1194–1198.
   PubMed Web of Science ®Google Scholar
• Tylicki L, Nieweglowsky T, Biedunkiewicz B. The influence of ozonated autohemotherapy on oxidative stress in hemodialyzed patients with atherosclerotic ischemia of lower limbs. Int J Artif Organs 2003;26:297–303.
   PubMed Web of Science ®Google Scholar
• Clavo B, Perez JL, Lopez L. Effect of ozone therapy on muscle oxygenation. J Altern Complement Med 2003;9:251–256.
   PubMed Web of Science ®Google Scholar
• Biedunkiewicz B, Tylicki L, Nieweglosky T, Burakowski S, Rutkowsky B. Clinical efficacy of ozonated autohemotherapy in hemodyalyzed patients with intermittent claudication: an oxygen controlled study. Int J Artif Organs 2004;27:29–34.
   PubMedGoogle Scholar
• De Monte A, van der Zee H, Bocci V. Major ozonated autohemotherapy in chronic limb ischemia with ulcerations. J Altern Complement Med 2005;11:363–367.
   PubMed Web of Science ®Google Scholar
• Di Paolo N, Bocci V, Salvo DP. Extracorporeal blood oxygenation and ozonation: a controlled trial in patients with peripheral arterial disease. Int J Artif Organs 2005;28:1039–1050.
   PubMedGoogle Scholar
• Bocci V, Chapter 9.3, Retinal degenerative disorders. In: Ozone. A new medical drug, 2nd edition, Dordrecht, The Netherlands: Springer; 2011. pp. 133–145.
   Google Scholar
• Andreula CE, Simonetti L, De Santis E, Agati R, Ricci R, Leonardi M. Minimally invasive oxygen-ozone therapy for lumbar disc herniation. Am J Neuroradiol 2003;24:996–1000.
   PubMed Web of Science ®Google Scholar
• Travagli V, Zanardi I, Silvietti A, Bocci V. A physicochemical investigation on the effects of ozone on blood. Int J Biol Macromol 2007;41:504–511.
   PubMed Web of Science ®Google Scholar
• Jacobs MT. Untersuchung uber Zwischendalle und tipische komplikationen in der ozon-suerstoff-therapie. OzonNarichten 1982;1–5.
   Google Scholar
• Bocci V. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res 2006;37:425–435.
   PubMed Web of Science ®Google Scholar
• Shinriki N, Suzuki T, Takama K, Fukunaga K, Ohgiya S, Kubota K, . Susceptibilities of plasma antioxidants and erythrocyte constituents to low levels of ozone. Haematologica 1998;29:229–239.
   Google Scholar
• Pryor WA, Squadrito GL, Friedman M. The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic Biol Med 1995;19:935–941.
   PubMed Web of Science ®Google Scholar
• Long EK, Picklo Sr MJ. Trans-4-hydroxy-2-hexenal, a product of n-3 fatty acid peroxidation: make some room HNE. Free Radic Biol Med 2010;49:1–8.
   PubMed Web of Science ®Google Scholar
• Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993;84:407–412.
   PubMed Web of Science ®Google Scholar
• Bocci V, Valacchi G, Corradeschi F, Aldinucci C, Silvestri S, Paccagnini E, . Studies on the biological effects of ozone: 7. Generation of reactive oxygen species (ROS) after exposure of human blood to ozone. J Biol Regul Homeost Agents 1998;12:67–75.
   PubMed Web of Science ®Google Scholar
• Galleano M, Puntarulo S. Role of antioxidants on the erythrocytes resistance to lipid peroxidation after acute iron overload in rats. Biochim Biophys Acta 1995;1271:321–326.
   PubMedGoogle Scholar
• Packer L. Roy S, Sen CK. Alpha-lipoic acid: a metabolic antioxidant and potential redox modulator of transcription. Adv Pharmacol 1997;38:79–101.
   PubMedGoogle Scholar
• Mendiratta S, Qu Z-C, May JM. Erythrocyte ascorbate recycling: antioxidant effects in blood. Free Radic Bio1 Med 1998;24:789–797.
   PubMed Web of Science ®Google Scholar
• Mendiratta S, Qu ZC, May JM. Enzyme-dependent ascorbate recycling: in human erythrocytes: role of thioredoxin reductase. Free Radic Biol Med 1998;25:221–228.
   PubMed Web of Science ®Google Scholar
• Bocci V, Aldinucci C. Biochemical modifications induced in human blood by oxygenation-ozonation. J Biochem Mol Toxicol 2006;20:133–138.
   PubMed Web of Science ®Google Scholar
• Mudd JB, Dawson PJ, Santrock J. Ozone does not react with human erythrocytes membrane lipids. Arch Biochem Biophis 1997;341:251–258.
   PubMedGoogle Scholar
• Antunes F, Cadenas E. Estimation of H2O2 gradients across biomembranes. FEBS Lett 2000;475:121–126.
   PubMed Web of Science ®Google Scholar
• Stone JR, Collins T. The role of hydrogen peroxide in endothelial proliferative respomses. Endothelium 2002;9:231–238.
   PubMedGoogle Scholar
• Stone JR, Yang S. Hydrogen peroxide: a signalling messenger. Antioxid Redox Signal 2006;8:243–270.
   PubMed Web of Science ®Google Scholar
• Forman HJ, Hydrogen peroxide: the good, the bad and the ugly. In Valacchi G, Davis P (eds.). Oxidants in biology. Dordrecht, The Netherland: Springer; 2008. pp. 1–17.
   Google Scholar
• Bocci V, Oxygen-ozonetherapy. A critical evaluation. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2002.
   Google Scholar
• Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 1986;47:921–928.
   PubMed Web of Science ®Google Scholar
• Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994;12:141–179.
   PubMed Web of Science ®Google Scholar
• Paulesu L, Luzzi E, Bocci V. Studies on the biological effects of ozone: 2. Induction of tumor necrosis factor (TNF-alpha) on human leukocytes. Lymphokine Cytokine Res 1991;10:409–412.
   PubMedGoogle Scholar
• Bocci V, Luzzi E, Corradeschi F, Paulesu L, Di Stefano A. Studies on the biological effects of ozone: 3. An attempt to define conditions for optimal induction of cytokines. Lymphokine Cytokine Res 1993;12:121–126.
   PubMedGoogle Scholar
• Bocci V, Luzzi E, Corradeschi F, Paulesu L, Rossi R, Cardaioli E, . Studies on the biological effects of ozone: Cytokine production and glutathione levels in human erythrocytes. J Biol Regul Homeost Agents 1993;7:133–138.
   PubMed Web of Science ®Google Scholar
• Bocci V, Valacchi G, Corradeschi F, Fanetti G. Studies on the biological effects of ozone: 8. Effects on the total antioxidant status and on interleukin-8 production. Mediators Inflamm 1998;7:313–317.
   PubMed Web of Science ®Google Scholar
• Bocci V, Valacchi G, Rossi R, Giustarini D, Paccagnini E, Pucci AM, , Studies on the biological effects of ozone: 9. Effects of ozone on human platelets. Platelets 1999;10:110–116.
   PubMed Web of Science ®Google Scholar
• Valacchi G, Bocci V. Studies on the biological effects of ozone: 10. Release of factors from ozonated human platelets. Mediators Inflamm 1999;8:205–209.
   PubMed Web of Science ®Google Scholar
• , VZanardi I, Bernini P, Nepi S, Tenori L, Bocci V. Effects of ozone blood treatment on the metabolite profile of human blood. Int J Toxicol 2010;29:165–174.
   PubMedGoogle Scholar
• Carballal S, Alvarez B, Turell L. Sulfenic acid in human serum albumin. Amino Acids 2007;32:543–551.
   PubMed Web of Science ®Google Scholar
• Dianzani MU. 4-Hydroxynonenal and cell signalling. Free Radic Res 1998;28:553–560.
   PubMed Web of Science ®Google Scholar
• Yang YS, Sharma R, Sharma A, Awasthi S, Awasthi YC. Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling. Acta Biochim Pol 2003;50:319–336.
   PubMed Web of Science ®Google Scholar
• Poli G, Schaur RJ, Siems WG and Leonarduzzi G. 4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med Res Rev 2008; 28:569 631.
   PubMed Web of Science ®Google Scholar
• Niki E, Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med 2009;47:469–484.
   PubMed Web of Science ®Google Scholar
• Aldini G, Gamberoni I, Orioli M, Beretta G, Regazzoni I, Maffei Facino R, . Mass spectrometric characterization of covalent modification of human serum albumin by 4-hydroxy-trans-2-nonenal. J Mass Spectrom 2006;41:1149–1161.
   PubMed Web of Science ®Google Scholar
• Aldini G, Vistoli G, Regazzoni L, Gamberoni I, Facino RM, Yamaguchi S, . Albumin is the main nucleophilic target of human plasma: a protective role against pro-atherogenic electrophilic reactive carbonyl species? Chem Res Toxicol 2008;21:824–835.
   PubMed Web of Science ®Google Scholar
• Siems W, Grune T. Intracellular metabolism of 4-hydroxynonenal. Mol Aspects Med 2003;24:167–175.
   PubMedGoogle Scholar
• Petersen DR, Doorn JA. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 2004;37:937–945.
   PubMed Web of Science ®Google Scholar
• Awasthi YC, Ansari GA, Awasthi S. Regulation of 4-hydroxynonenal mediated signaling by glutathione S-transferase. Methods Enzymol 2005;401:379–407.
   PubMed Web of Science ®Google Scholar
• Alary J, Geuraud F, Cravedi JP. Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways. Mol Aspects Med 2003;24:177–187.
   PubMedGoogle Scholar
• Alary J, Bravais F, Cravedu JP, Debrauwer L, Rao D, Bories G. Mercapturic acid conjugates as urinary end metabolites of the lipid peroxidation product 4-hydroxynonenal in the rat. Chem Res Toxicol 1995;8:34–39.
   PubMed Web of Science ®Google Scholar
• Valacchi G, Bocci V. Studies on the biological effects of ozone: 11. Release of factors from human endothelial cells. Mediators Inflamm. 2000;9:271–276.
   PubMed Web of Science ®Google Scholar
• Leonarduzzi G, Robbesyn F, Poli G. Signaling kinases modulated by 4-hydroxynonenal. Free Radic Biol Med 2004;37:1694–1702.
   PubMed Web of Science ®Google Scholar
• Motohashi H, Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 2004;10:549–557.
   PubMed Web of Science ®Google Scholar
• Zhang DD. Mechanistic studies of the NRF2-KEAP1 signaling pathway. Drug Metab Rev 2006;38:769–789.
   PubMed Web of Science ®Google Scholar
• Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu S, . Activation of Nrf2-antioxidant signaling attenuates NF kappa B-inflammatory response and elicits apoptosis. Biochem Pharmacol 2008;76:1485–1489.
   PubMed Web of Science ®Google Scholar
• Kwak MK, Kensler TW. Targeting NRF2 signaling for cancer chemoprevention. Toxicol Appl Pharmacol 2010; 244:66–76.
   PubMed Web of Science ®Google Scholar
• Dickinson DA, Iles KE, Watanabe N, Iwamoto T, Zhang H, Krzywanski DM, . 4-Hydroxynonenal induces glutamate cysteine ligase through JNK in HBE1 cells. Free Radic Biol Med 2002;33:974–987.
   PubMed Web of Science ®Google Scholar
• Chen ZH, Saito Y, Yoshida Y, Sekine A, Noguchi N, Niki E. 4-Hydroxynonenal induces adaptive response and enhance PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J Biol Chem 2005;280:41921–41927.
   PubMed Web of Science ®Google Scholar
• Tanito M, Agbaga MP, Anderson RE. Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro. Free Radic Biol Med 2007;42:1838–1850.
   PubMedGoogle Scholar
• Ishikado A, Nishio Y, Morino K, Ugi S, Kondo H, Makino T, . Low concentration of 4-hydroxy hexenal increases heme oxygenase-1 expression through activation of Nrf2 and antioxidative activity in vascular endothelial cells. Biochem Biophys Res Commun 2010;402:99–104.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sano M, Shinmura K, Tamaki K, Katsumata Y, . 4-Hydroxy-2-nonenal protects against cardiac ischemia reperfusion injury via the Nrf2-dependent pathway. J Mol Cell Cardiol 2010;49:576–586.
   PubMed Web of Science ®Google Scholar
• Iles KE, Dickinson DA, Wigley AF, Welty NE, Blank V, Forman HJ. HNE increases HO-1 through activation of the ERK patway in pulmonary epithelial cells. Free radical Biol Medic 2005;39:355–364.
   PubMed Web of Science ®Google Scholar
• Sagai M, Bocci V. Mechanisms of action involved in ozone therapy: is healing induced via a mild oxidative stress? Med Gas Res 2011 DOI: 10.1186/2045-9912-1-29.
   PubMedGoogle Scholar
• Bocci V, Aldinucci C, Mosci F, Carraro F, Valacchi G. Ozonation of human blood induces a remarkable upregulation of heme oxygenase-1 and heat stress protein-70. Mediators Inflammation, DOI: 10.1155/2007/26785.
   Google Scholar
• Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008;60:79–127.
   PubMed Web of Science ®Google Scholar
• Talalay P, Fahey JW, Holtzclaw WD, Prestera T, Zhang Y. Chemoprotection against cancer by phase 2 enzyme induction. Toxicol Lett 1995;82–83:173–179.
   PubMed Web of Science ®Google Scholar
• Benson H, Friedman R. Harnessing the power of the placebo effect and renaming it “remembered wellness”. Annu Rev Med 1996;47:193–199.
   PubMed Web of Science ®Google Scholar
• Grossman A, Perry L, Schally AV, Rees Lesley H, Nieuwenhuyzen Kruseman AC, New hypothalamic hormone, corticotrophin-releasing factor, specifically stimulates the release of adrenocorticotropic hormone and cortisol in man. Lancet 1982;921–922.
   PubMedGoogle Scholar
• Michaud K, Matheson K, Kelly O, Anisman H. Impact of stressors in a natural context on release of cortisol in healthy adult humans: a meta-analysis. Stress 2008;11:177–197.
   PubMed Web of Science ®Google Scholar
• Baulieu EE, Robel P. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc Natl Acad Sci USA 1998;95:4089–4091.
   PubMed Web of Science ®Google Scholar
• Moncada S, Vane JR. Prostacyclin: homeostatic regulator or biological curiosity? 1981;61:369–372.
   Google Scholar
• Schulz S, Ninke S, Watzer B, Nusing RM. Ozone induces synthesis of systemic prostacyclin by cyclooxygenase-2 dependent mechanism in vivo. Biochem Pharmacol 2012;83:506–513.
   PubMedGoogle Scholar
• Viru A, Tendzegolskis Z. Plasma endorphin species during dynamic exercise in humans. Clin Physiol 1995;15:73–79.
   PubMedGoogle Scholar
• Burgassi S, Zanardi I, Travagli V, Montomoli E, Bocci V. How much ozone bactericidal activity is compromised by plasma components? J Appl Microbiol 2009;106:1715–1721.
   PubMedGoogle Scholar
• Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J 2002;16:1792–1798.
   PubMed Web of Science ®Google Scholar
• Bocci V, Zanardi I, Travagli V. Ozone acting on human blood yields a hormetic dose–response relationship. J Translational Med 2011;9:66–77.
   PubMed Web of Science ®Google Scholar